The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Active Surveillance for Prostate Cancer: Progress and Promise
Open accessAbstract
Widespread prostate-specific antigen (PSA) –based screening and aggressive treatment of prostate cancer have reduced mortality rates substantially, but both remain controversial in large part because of high rates of overdiagnosis and overtreatment of otherwise indolent tumors. Active surveillance—or close monitoring of PSA levels combined with periodic imaging and repeat biopsies—is gaining acceptance as an alternative initial management strategy for men with low-risk prostate cancer. In reported series, rates of progression to active treatment with intermediate-term follow-up have ranged from 14% to 41%, and likelihood of subsequent cure with surgery or radiation does not seem to be compromised by an initial trial of surveillance. Two related challenges to broader acceptance of surveillance are better characterization at time of diagnosis of the risk of progression (including likelihood that given tumor may have been undersampled by diagnostic biopsy) and validation of optimal end points once surveillance begins. Both are subjects of intense ongoing investigation, with emerging biomarkers and novel imaging tests expected to facilitate decision making substantially. Recent reports have suggested active surveillance can be a cost-effective approach and preserve quality of life, but these questions must be assessed more definitively in prospective cohorts. Ultimately, by minimizing the harms of overtreating low-risk prostate cancer, active surveillance may help settle the controversy surrounding prostate cancer screening and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Effect of Dutasteride on the Risk of Prostate Cancer
Andriole, G. L., Bostwick, D. G., Brawley, O. W., Gomella, L. G., Marberger, M., Montorsi, F., Pettaway, C. A., Tammela, T. L., Teloken, C., Tindall, D. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908127 · Cited by 1,152
Klotz, L., Zhang, L., Lam, A., Nam, R., Mamedov, A., & Loblaw, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2180 · Cited by 1,074
Self-citationTime Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0133 · Cited by 1,006
Self-citationMortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 745
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Bill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Tosoian, J. J., Trock, B. J., Landis, P., Feng, Z., Epstein, J. I., Partin, A. W., Walsh, P. C., & Carter, H. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8112 · Cited by 596
Nam, R. K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L. H., Loblaw, D. A., Trachtenberg, J., Stanimirovic, A., Simor, A. E., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.015 · Cited by 592
Self-citationProstate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
Self-citationRethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
INTENSIVE LIFESTYLE CHANGES MAY AFFECT THE PROGRESSION OF PROSTATE CANCER
ORNISH, D., WEIDNER, G., FAIR, W. R., MARLIN, R., PETTENGILL, E. B., RAISIN, C. J., DUNN-EMKE, S., CRUTCHFIELD, L., JACOBS, F. N., BARNARD, R. J., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000169487.49018.73 · Cited by 474
Self-citationContemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
Cooperberg, M. R., Broering, J. M., Kantoff, P. W., & Carroll, P. R. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.135 · Cited by 442
Self-citationOutcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., diTommaso, D., Karnofski, K., Gulati, R., Penson, D. F., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-007-9083-8 · Cited by 423
Active surveillance for the management of prostate cancer in a contemporary cohort
Dall'Era, M. A., Konety, B. R., Cowan, J. E., Shinohara, K., Stauf, F., Cooperberg, M. R., Meng, M. V., Kane, C. J., Perez, N., Master, V. A., et al. (2008) · Cancer · doi:10.1002/cncr.23502 · Cited by 404
Self-citationNam, R. K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L. H., Loblaw, D. A., Trachtenberg, J., Stanimirovic, A., Simor, A. E., et al. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.11.043 · Cited by 402
Self-citationImpact of Age at Diagnosis on Prostate Cancer Treatment and Survival
Bechis, S. K., Carroll, P. R., & Cooperberg, M. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2075 · Cited by 392
Self-citationKATTAN, M. W., EASTHAM, J. A., WHEELER, T. M., MARU, N., SCARDINO, P. T., ERBERSDOBLER, A., GRAEFEN, M., HULAND, H., KOH, H., SHARIAT, S. F., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091806.70171.41 · Cited by 350
Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp122 · Cited by 336
Self-citationEffect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer
Thompson, I. M., Chi, C., Ankerst, D. P., Goodman, P. J., Tangen, C. M., Lippman, S. M., Lucia, M. S., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj307 · Cited by 323
Ornish, D., Magbanua, M. J. M., Weidner, G., Weinberg, V., Kemp, C., Green, C., Mattie, M. D., Marlin, R., Simko, J., Shinohara, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803080105 · Cited by 300
Self-citationOutcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
Cooperberg, M. R., Cowan, J. E., Hilton, J. F., Reese, A. C., Zaid, H. B., Porten, S. P., Shinohara, K., Meng, M. V., Greene, K. L., & Carroll, P. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4252 · Cited by 283
Self-citationWolters, T., Roobol, M. J., van Leeuwen, P. J., van den Bergh, R. C. N., Hoedemaeker, R. F., van Leenders, G. J. L. H., Schröder, F. H., & van der Kwast, T. H. (2011) · Journal of Urology · doi:10.1016/j.juro.2010.08.082 · Cited by 280
Soloway, M. S., Soloway, C. T., Eldefrawy, A., Acosta, K., Kava, B., & Manoharan, M. (2010) · European Urology · doi:10.1016/j.eururo.2010.08.027 · Cited by 272
Hayes, J. H., Ollendorf, D. A., Pearson, S. D., Barry, M. J., Kantoff, P. W., Stewart, S. T., Bhatnagar, V., Sweeney, C. J., Stahl, J. E., & McMahon, P. M. (2010) · JAMA · doi:10.1001/jama.2010.1720 · Cited by 257
Anxiety and distress during active surveillance for early prostate cancer
van den Bergh, R. C. N., Essink‐Bot, M., Roobol, M. J., Wolters, T., Schröder, F. H., Bangma, C. H., & Steyerberg, E. W. (2009) · Cancer · doi:10.1002/cncr.24446 · Cited by 230
Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj308 · Cited by 227
Latini, D. M., Hart, S. L., Knight, S. J., Cowan, J. E., Ross, P. L., DuChane, J., Carroll, P. R., & CaPSURE Investigators (2007) · Journal of Urology · doi:10.1016/j.juro.2007.05.039 · Cited by 223
Self-citationDelayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome
Warlick, C., Trock, B. J., Landis, P., Epstein, J. I., & Carter, H. B. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj072 · Cited by 219
van As, N. J., Norman, A. R., Thomas, K., Khoo, V. S., Thompson, A., Huddart, R. A., Horwich, A., Dearnaley, D. P., & Parker, C. C. (2008) · European Urology · doi:10.1016/j.eururo.2008.02.039 · Cited by 216
Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer
Conti, S. L., Dall'Era, M., Fradet, V., Cowan, J. E., Simko, J., & Carroll, P. R. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.11.107 · Cited by 189
Self-citationFujita, K., Landis, P., McNeil, B. K., & Pavlovich, C. P. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.08.044 · Cited by 171
van As, N. J., de Souza, N. M., Riches, S. F., Morgan, V. A., Sohaib, S. A., Dearnaley, D. P., & Parker, C. C. (2009) · European Urology · doi:10.1016/j.eururo.2008.11.051 · Cited by 169
Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice
Zierhut, M. L., Yen, Y.-F., Chen, A. P., Bok, R., Albers, M. J., Zhang, V., Tropp, J., Park, I., Vigneron, D. B., Kurhanewicz, J., et al. (2010) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2009.10.003 · Cited by 166
Roemeling, S., Roobol, M. J., de Vries, S. H., Wolters, T., Gosselaar, C., van Leenders, G. J. L. H., & Schröder, F. H. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.053 · Cited by 160
Donovan, J., Lane, J. A., Peters, T. J., Brindle, L. A., Salter, E., Gillatt, D. A., Powell, P. H., Bollina, P. R., Neal, D. E., & Hamdy, F. C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.02.010 · Cited by 159
Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
Crawford, E. D., Grubb, R., Black, A., Andriole, G. L., Chen, M.-H., Izmirlian, G., Berg, C. D., & D'Amico, A. V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5979 · Cited by 159
Lane, J. A., Hamdy, F. C., Martin, R. M., Turner, E. L., Neal, D. E., & Donovan, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.016 · Cited by 149
Auprich, M., Chun, F. K. ‐., Ward, J. F., Pummer, K., Babaian, R. J., Augustin, H., Luger, F., Gutschi, S., Budäus, L., Fisch, M. M., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.10.024 · Cited by 147
Barocas, D. A., Cowan, J. E., Smith, J. A. J., Carroll, P. R., & CaPSURE Investigators (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.06.019 · Cited by 134
Self-citationCumulative cost pattern comparison of prostate cancer treatments
Wilson, L., Tesoro, R., Elkin, E. P., Sadetsky, N., Broering, J. M., Latini, D. M., DuChane, J., Mody, R., & Carroll, P. R. (2006) · Cancer · doi:10.1002/cncr.22433 · Cited by 128
Self-citationActive surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L. H. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.002 · Cited by 119
Self-citationNewcomb, L. F., Brooks, J. D., Carroll, P. R., Feng, Z., Gleave, M. E., Nelson, P. S., Thompson, I. M., & Lin, D. W. (2009) · Urology · doi:10.1016/j.urology.2009.05.050 · Cited by 79
Self-citationA nomogram for predicting low‐volume/low‐grade prostate cancer
Nakanishi, H., Wang, X., Ochiai, A., Trpkov, K., Yilmaz, A., Donnelly, J. B., Davis, J. W., Troncoso, P., & Babaian, R. J. (2007) · Cancer · doi:10.1002/cncr.23055 · Cited by 69
Fleshner, N. E., Gomella, L. G., Cookson, M. S., Finelli, A., Evans, A., Taneja, S. S., Lucia, M. S., Wolford, E. T., Somerville, M. C., & Rittmaster, R. S. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.05.006 · Cited by 68
Active Surveillance With Selective Radical Treatment for Localized Prostate Cancer
van As, N. J., & Parker, C. C. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318156ff65 · Cited by 52
Measuring illness uncertainty in men undergoing active surveillance for prostate cancer
Bailey, D. E., Wallace, M. E., Latini, D. M., Hegarty, J. M., Carroll, P. R., Klein, E. A., & Albertsen, P. C. (2009) · Applied Nursing Research · doi:10.1016/j.apnr.2009.08.001 · Cited by 42
Self-citationParsons, J. K., Newman, V. A., Mohler, J. L., Pierce, J. P., Paskett, E. D., & Marshall, J. R. (2008) · Urology · doi:10.1016/j.urology.2007.11.050 · Cited by 38
SPCG-4: A Needed START to PIVOTal Data to Promote and ProtecT Evidence-Based Prostate Cancer Care
Wilt, T. J. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn259 · Cited by 30
Cited by
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate
Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., Larson, P. E. Z., Harzstark, A. L., Ferrone, M., van Criekinge, M., Chang, J. W., Bok, R., Park, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006070 · Cited by 1,286
Klein, E. A., Cooperberg, M. R., Magi-Galluzzi, C., Simko, J. P., Falzarano, S. M., Maddala, T., Chan, J. M., Li, J., Cowan, J. E., Tsiatis, A. C., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.05.004 · Cited by 659
Self-citationActive Surveillance for Prostate Cancer: A Systematic Review of the Literature
Dall’Era, M. A., Albertsen, P. C., Bangma, C., Carroll, P. R., Carter, H. B., Cooperberg, M. R., Freedland, S. J., Klotz, L. H., Parker, C., & Soloway, M. S. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.072 · Cited by 602
Self-citationQuality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Cooperberg, M. R., Simko, J. P., Cowan, J. E., Reid, J. E., Djalilvand, A., Bhatnagar, S., Gutin, A., Lanchbury, J. S., Swanson, G. P., Stone, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.4396 · Cited by 351
Self-citation
Metadata
- Authors
- Cooperberg, M. R., Carroll, P. R., & Klotz, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-09-20
- Volume
- 29
- Issue
- 27
- Pages
- 3669-3676
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2101436815
- Cited by
- 290
- References
- 59
- FWCI
- 31.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.